INVO Bioscience is a medical device company. Co.'s focus is the manufacture and sale of the INVOcell device and the INVO technology to provide an alternative infertility treatment. The INVOcell device is used for the incubation of eggs and sperm during fertilization and early embryo development. The INVOcell utilizes the women's vagina as an incubator to support a fertilization and embryo development environment, and infertility treatment. The INVOcell system consists of: INVOcell Culture Device, which is used in preparing, holding, and transferring human gametes or embryos; and INVOcell Retention Device, which is used to aid in retention of the INVOcell Device in the vaginal cavity. The INVO stock yearly return is shown above.
The yearly return on the INVO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the INVO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|